In bladder cancer, tumor-suppressor genes such as RASSF1A, RUNX3, CDH13, and HOXA9 have been reported to undergo promoter hypermethylation, resulting in loss of tumor-inhibitory function (14, 15). The gene discussed is HOXA9; the disease is neoplasm.